Rapamycin (Sirolimus)

Rapamycin (sirolimus) is an mTOR (mechanistic Target of Rapamycin) inhibitor that blocks protein synthesis and cellular growth pathways. This compound mimics caloric restriction effects, potentially extending lifespan while providing immunosuppressive and anti-aging benefits.

Origin & History

Rapamycin, also known as Sirolimus, is a macrolide compound originally discovered in soil samples from Easter Island. It is produced by the bacterium Streptomyces hygroscopicus and is primarily used as an immunosuppressant in organ transplantation.

Historical & Cultural Context

Discovered in the 1970s on Easter Island, rapamycin has been used in medicine primarily for its immunosuppressive properties. It is named after the island's native name, Rapa Nui.

Health Benefits

- Inhibits the mTOR pathway, which may extend lifespan by mimicking the effects of caloric restriction. This can lead to improved longevity and healthspan. - Reduces immune system overactivity, aiding in the prevention of autoimmune diseases by balancing immune responses. - Supports cardiovascular health by reducing inflammation and preventing arterial plaque buildup, lowering the risk of heart disease. - Enhances cognitive function by reducing neuroinflammation, potentially lowering the risk of Alzheimer's disease. - Promotes skin health by reducing signs of aging, such as wrinkles and age spots, through its anti-inflammatory properties. - Supports metabolic health by improving insulin sensitivity, which can help maintain healthy blood sugar levels and prevent diabetes. - Aids in cancer prevention by inhibiting cell proliferation and promoting apoptosis in cancerous cells.

How It Works

Rapamycin binds to the intracellular protein FKBP12 to form a complex that inhibits mTOR Complex 1 (mTORC1), blocking downstream signaling pathways including S6K1 and 4E-BP1. This inhibition reduces protein synthesis, autophagy activation, and cellular senescence while mimicking the molecular effects of caloric restriction. The compound also affects mTOR Complex 2 (mTORC2) with chronic use, influencing Akt signaling and glucose metabolism.

Scientific Research

Numerous RCTs and animal studies have explored rapamycin's effects on lifespan extension and cancer inhibition. Meta-analyses support its efficacy in organ transplant patients.

Clinical Summary

Human studies on rapamycin for longevity are limited, with most anti-aging research conducted in animal models showing 20-30% lifespan extension in mice. Clinical trials have primarily focused on its immunosuppressive effects in organ transplant patients, with doses of 1-5mg daily. Small pilot studies suggest potential benefits for age-related decline, but large-scale human longevity trials are lacking. The evidence for anti-aging effects in humans remains preliminary and requires further investigation.

Nutritional Profile

- Macrolide compound with immunosuppressive properties. - Inhibits the mammalian target of rapamycin (mTOR) pathway. - Derived from Streptomyces hygroscopicus bacteria.

Preparation & Dosage

Doses for immunosuppression range from 2-5 mg per day, but lower doses may be used for longevity purposes. Consult a healthcare provider before use.

Synergy & Pairings

Metformin,Resveratrol,NAD+

Safety & Interactions

Common side effects include increased infection risk, delayed wound healing, mouth ulcers, and elevated cholesterol levels. Rapamycin significantly interacts with CYP3A4 inhibitors like ketoconazole and grapefruit juice, potentially increasing blood levels. It's contraindicated during pregnancy and breastfeeding due to potential developmental risks. Regular monitoring of blood levels, lipid profiles, and immune function is recommended due to its potent immunosuppressive effects.